Dave Weber, PhD, reviews how SmartAssist technology determines and tracks trends in cardiac output (CO) and cardiac power output (CPO) and how these metrics can be used to guide a successful Impella® heart pump weaning procedure.
Learn when and how to use echocardiography to visualize in real-time the relationship of the Impella 5.5 with SmartAssist to structures within the left ventricle.
Ameloot et al. report significant reduction in myocardial injury with target MAP between 80/85 and 100 mmHg in post-cardiac arrest patients with shock after AMI.
This educational video defines hemolysis, reviews the clinical signs and symptoms for diagnosing hemolysis and provides tips to reduce the risk of hemolysis with Impella heart pumps.
To the surprise of all the treating cardiologists, the patient presented with an ejection fraction of 5%, which improved to 55% after support with Impella RP® and Impella CP®.
NPS-1674
This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].
The Protected PCI community
is now on HeartRecovery.com
Providing education and training to help health care professionals
recover hearts, oxygenate the body and save lives.